OPR - Delayed Quote • USD ARCT Sep 2024 30.000 put (ARCT240920P00030000) Follow 6.70 0.00 (0.00%) At close: April 19 at 11:13 AM EDT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for ARCT240920P00030000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: ARCT Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024 Arcturus Therapeutics Holdings Inc (ARCT) Insider Sells Shares Arcturus Therapeutics Holdings Inc's Chief Scientific Officer & COO Pad Chivukula Sells ... Arcturus Therapeutics Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag 12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2023 Earnings Call Transcript Q4 2023 Arcturus Therapeutics Holdings Inc Earnings Call Arcturus Therapeutics Reports Fiscal Year 2023 Financial Results and Pipeline Developments Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates Arcturus Therapeutics: Q4 Earnings Snapshot Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress Arcturus (ARCT) Stock Surges 73% in 3 Months: Here's Why
